Fidelio has secured an additional SEK 3 billion in capital. In addition to the team at Fidelio, investors include a select group of successful Nordic industrialists, entrepreneurs and families. Fidelio will maintain its differentiated strategy of building global champions in niche markets, by scaling small to medium-sized businesses around the world.
Indical has acquired the Svanova product portfolio from Boehringer Ingelheim. Through the acquisition, Indical becomes the exclusive provider of Svanova’s veterinary testing products, which include around 25 livestock ELISA assays. Svanova arose out of the Swedish Veterinary Institute, a pioneer
Read morePDL enters Norway by establishing two padel destinations in the Oslo region with 25 padel courts in total. PDL has secured a substantial number of further locations across the country, which are due to open later this year. The expansion
Read moreWith the formation of Movora, Fidelio establishes a global leader in the veterinary orthopedic market. Movora consists of three brands; Kyon (Switzerland), BioMedtrix (USA) and VOI (USA), acquired by Fidelio during 2019 and 2020. Movora has 8 offices in 5
Read more